Analystreport

Correvio Pharma Corp (NASDAQ: CORV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

CORREVIO PHARMA CORP ORDINARY SHARES  (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report